Approvals/TGA/Hospira Irinotecan (Irinotecan hydrochloride) 20mg/mL concentrate for solution for infusion 100mg/5mL vial.

Approved

STANDARD

Hospira Irinotecan (Irinotecan hydrochloride) 20mg/mL concentrate for solution for infusion 100mg/5mL vial.

Hospira Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2b46759fefed3c66
Product Name: Hospira Irinotecan (Irinotecan hydrochloride) 20mg/mL concentrate for solution for infusion 100mg/5mL vial.
Artg Id: 106984
Artg Name: Hospira Irinotecan (Irinotecan hydrochloride) 20mg/mL concentrate for solution for infusion 100mg/5mL vial.
Sponsor: Hospira Australia Pty Ltd
Company Detail Path: /organization/hospira-australia-pty-ltd
Artg Date: 2004-08-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2b46759fefed3c66

Type

Standard